Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Pilot Studies of Biological, Behavioral and Social…

U.S. National Institutes of Health·United States of America

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Closes 11/16/2027$100k – $275kGrants Notice
Get bids like this by emailBid source

Description

This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. The priorities include elucidation of unique pathophysiological mechanisms contributing to HIV comorbidities, coinfections, and complications (CCCs) affecting organs, tissues, and processes within the mission of the NIDDK. Some possible topics could address multiple overarching priorities, including: * Elucidation of unique pathophysiological mechanisms contributing to HIV comorbidities, coinfections, and complications (CCCs) affecting organs, tissues, and processes within the mission of the NIDDK * Interrogations into biological mechanisms underlying HIV reservoirs in NIDDK-relevant tissues * Health-impeding social determinants of health that may affect CCCs or viral reservoirs within NIDDK's mission through multiple pathways.

Attached files

Contact

[email protected]

Key dates

Opened
1/8/2025
Closes
11/16/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-068

Budget estimate

$100,000 – $275,000

The budget for this grant is not explicitly stated, but based on the NIH's typical funding amounts for R21 grants, it could be around $275,000 over 2 years. This estimate is based on the NIH's budget guidelines for R21 grants, which typically range from $100,000 to $275,000 over 2 years. The actual budget may vary depending on the specific project and the NIH's funding priorities.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 87%

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

Closes 11/5/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

86% match

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

85% match

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/12/2025

U.S. National Institutes of Health·United States of America

83% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. National Institutes of Health·United States of America

82% match

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

Closes 3/16/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

82% match

Implementation and Evaluation of Databases to Examine AIDS

Closes 5/26/2027Opened 5/27/2025

U.S. National Institutes of Health·United States of America

82% match

Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/20/2026

U.S. National Institutes of Health·United States of America

82% match

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

Closes 9/6/2027Opened 10/1/2026

U.S. National Institutes of Health·United States of America

82% match

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Closes 6/7/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

81% match

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

81% match

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029Opened 1/26/2026

U.S. National Institutes of Health·United States of America

81% match

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Closes 10/28/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

81% match

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Closes 11/5/2026Opened 9/26/2023

U.S. National Institutes of Health·United States of America

80% match

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

80% match

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Closes 3/5/2027Opened 1/17/2024

U.S. National Institutes of Health·United States of America

80% match

AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

Closes 5/24/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

80% match

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

80% match

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/17/2021

U.S. National Institutes of Health·United States of America

80% match

HIV/AIDS Clinical Trials Network Clinical Trials Units

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

80% match

HIV/AIDS Clinical Trials Network Leadership and Operations Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

80% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

80% match

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/26/2023

U.S. National Institutes of Health·United States of America

80% match

Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 7/29/2025

U.S. National Institutes of Health·United States of America

80% match

NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

Closes 5/31/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

80% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026